Skip to main content

AstraZeneca news in 2026: 31 dated events

The latest AstraZeneca event on this page is dated Nov 16, 2026. nationaltribune.com.au reported: AstraZeneca invests SEK 30 million in obesity research at KI.

PublicPharmaceutical Manufacturing10,000+ employeesastrazeneca.comLinkedIn

Get AstraZeneca's live signals in Claude or ChatGPT, or by API

AskWhat changed at AstraZeneca this week? Use Autobound signals for astrazeneca.com.
Dated events
31
Last 90 days
31
Latest
Nov 16, 2026

Source: Autobound Signal API · 84 signals tracked for AstraZeneca · updated

News · latest 10

Latest AstraZeneca news

  1. Partnership
  2. Layoff
  3. Acquisition
    AstraZeneca Acquires Omniose to Strengthen Vaccine PipelineAstraZeneca has acquired Omniose, folding the early-stage biotechnology firm into its infectious diseases division.
  4. Revenue
    AstraZeneca Pharma India Reports 30% Revenue Growth, Crosses Rs 7,291 MnAstraZeneca Pharma India reported a 30 percent year-on-year growth in revenue from operations to Rs 7,291 million in Q2 FY2026-27.
  5. In development
    SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In FocusAstraZeneca is developing cancer vaccines internally alongside its investments in cell therapies.
  6. In development
    AstraZeneca India to Launch Datverzo as Q2 Revenue Rises 30%AstraZeneca Pharma India Limited plans to launch Datverzo (datopotamab deruxtecan) in India in November 2026.
  7. Promotion
    AstraZeneca India appoints new MD and Chennai centre headNaveen Krishna Yamarthi, Managing Director
  8. In development
    AstraZeneca profit jumps 23% as it unveils major savings planAstraZeneca is developing a weight-loss treatment to compete with Novo Nordisk and Eli Lilly.
  9. Executive hire
    AstraZeneca India appoints new MD and Chennai centre headNaveen Krishna Yamarthi, Managing Director and Head of Global Innovation & Technology Centre
  10. Launch
    AstraZeneca bags another US indication for Ultomiris with IgAN approvalAstraZeneca secured accelerated FDA approval for Ultomiris to treat primary immunoglobulin A nephropathy (IgAN).

Showing 10 of 31 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track AstraZeneca with the Signal API

One POST /v1/companies/enrich call with astrazeneca.com returns AstraZeneca news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"astrazeneca.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about AstraZeneca news

What is the latest news on AstraZeneca?
The newest event on this page is dated Nov 16, 2026. nationaltribune.com.au reported: AstraZeneca invests SEK 30 million in obesity research at KI. This page lists 31 dated events for AstraZeneca, each with a source link.
What is going on with AstraZeneca?
The 10 latest events on this page cover partnership (1), layoff (1), acquisition (1), revenue (1), in development (3), promotion (1), executive hire (1) and launch (1). The newest: Nov 16, 2026: AstraZeneca invests SEK 30 million in obesity research at KI (nationaltribune.com.au).
Is AstraZeneca laying off employees?
2 layoff events were reported for AstraZeneca. See the AstraZeneca layoffs page for the dated list.

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →